首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1391972

生物工程人造皮肤市场：按产品类型、按应用、按最终用户、按地区

Bioengineered Artificial Skin Market, By Product Type, By Application, By End User, By Geography

出版日期: 2023年11月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球生物工程人造皮肤市场规模将达33.2亿美元，复合年增长率为16.9%，2030年将达99.2亿美元。

报告范围		报告详情
基准年	2022年	2023年市场规模	33.2亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	16.90%	2030年市场规模预测	99.2亿美元

图 1. 按地区分類的全球生物工程人造皮肤市场

生物工程人造皮肤旨在承受表皮和真皮的功能，暂时使用，直到患者的皮肤屏障自然修復。生物工程皮肤用于解决长期深层皮肤伤口缝合过程而导致的严重疤痕。生物工程自体皮肤移植物源自于患者自身的皮肤细胞，并在少量皮肤或毛囊中生长或培养。生物工程人造皮肤专为重组皮肤附属器、色素沉着和神经而设计。人造皮肤可以替代或用于替代皮肤的外层及其下面的较厚层（表皮和真皮）。最常用的商业性真皮细胞替代品由天然细胞外基质成分组成，分为两类：去细胞细胞外基质和重建细胞外基质。

市场动态：

交通事故、烧伤和创伤相关事故数量增加，急慢性伤口发病率高（由于慢性病负担增加和老年人口增加），公众对各种皮肤治疗的认识不断提高，人造皮肤的需求不断增加预计是推动全球生物工程人造皮肤市场成长的主要因素。

例如，2021 年 6 月，美国食品药物管理局(FDA) 建议对涉及完整真皮层（剩余深层皮肤层）的烧伤（也称为深层烧伤）的临床上需要手术干预的成年患者进行手术干预。）核准StrataGraft 用于治疗StrataGraft 是一种层级构造支架（细胞纤维母细胞。

本研究的主要特点

本报告详细分析了全球生物工程人造皮肤市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据以下参数（例如公司亮点、产品系列、主要亮点、绩效和策略）介绍了全球生物工程人造皮肤市场的主要企业。
该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
全球生物工程人造皮肤市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
透过用于分析全球生物工程人造皮肤市场的各种策略矩阵，将促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.32 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	16.90%	2030 Value Projection:	US$ 9.92 Bn

Bioengineered skin is designed to undertake the functions of the epidermis and/or dermis as a temporary usage till the patient's skin barrier spontaneously repairs itself naturally. Bioengineered skin is used to address severe scars which represents the result of the closure process of extended and deep skin wounds. Bioengineered skin autografts are derived from the patient's own skin cells that are grown or cultured in small amounts of skin or hair follicles. Bioengineered artificial skin is designed for the reconstruction of skin appendages, pigmentation, and nerves. Artificial skin can replace or can be used to replace the outer layer of the skin or the thick layer just underneath it (epidermis and dermis). The most used commercially available acellular dermal substitutes are composed of natural extracellular matrix components and can be divided in two categories: decellularized extracellular matrices and reconstructed extracellular matrices.

Market Dynamics:

Rising number of road accidents, burns, and trauma-related incidents, high incidence of acute and chronic wounds (owing to the rise in burden of chronic diseases and growing geriatric population), increasing awareness among people about various skin treatments, and rise in demand for artificial skin are major factors expected to drive growth of the global bioengineered artificial skin market.

For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved StrataGraft for the treatment of adult patients with thermal burns, which contained intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns). StrataGraft is produced from two kinds of human skin cells (keratinocytes and dermal fibroblasts) grown together to make a bi-layered construct (a cellularized scaffold).

Key features of the study:

This report provides in-depth analysis of the global bioengineered artificial skin market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bioengineered artificial skin market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AbbVie, Genoskin, Smith and Nephew Inc, Genzyme Biosurgery, Vericel Corporation, AROA BIOSURGERY LIMITED, Integra LifeSciences Corp, COOK BIOTECH, Molnlycke Health Care AB, Avita Medical, MiMedx Group, Inc. and Organogenesis Holdings Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global bioengineered artificial skin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioengineered artificial skin market.

Detailed Segmentation:

By Product Type:
- Bilayered Bioengineered Artificial Skin
- Trilayered Bioengineered Artificial Skin
- Others
By Application:
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
- Acute Wounds
- Burns
- Surgical Wounds
- Others
- Others
By End User:
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- AbbVie
- Genoskin
- Smith and Nephew Inc
- Genzyme Biosurgery
- Vericel Corporation
- AROA BIOSURGERY LIMITED
- Integra LifeSciences Corp
- COOK BIOTECH
- Molnlycke Health Care AB
- Avita Medical
- MiMedx Group, Inc.
- Organogenesis Holdings Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Bioengineered Artificial Skin Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Bioengineered Artificial Skin Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Bilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Trilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Bioengineered Artificial Skin Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Burns
- Surgical Wounds
- Others
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Bioengineered Artificial Skin Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Bioengineered Artificial Skin Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- U.S.
- Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- AbbVie
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Genoskin
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Smith and Nephew Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Genzyme Biosurgery.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Vericel Corporation.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- AROA BIOSURGERY LIMITED
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Integra LifeSciences Corp
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- COOK BIOTECH.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Molnlycke Health Care AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Avita Medical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- MiMedx Group, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Organogenesis Holdings Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

生物工程人造皮肤市场：按产品类型、按应用、按最终用户、按地区

Bioengineered Artificial Skin Market, By Product Type, By Application, By End User, By Geography

市场动态：

本研究的主要特点

目录

第1章研究目的与前提

第2章市场展望

第3章市场动态、法规及趋势分析

第4章全球生物工程人造皮肤市场－冠状冠状病毒（COVID-19）大流行的影响

第5章全球生物工程人造皮肤市场，依产品类型，2018-2030

第6章全球生物工程人造皮肤市场，依应用分类，2018-2030

第7章全球生物工程人造皮肤市场，按最终用户划分，2018-2030 年

第8章2018-2030年全球生物工程人造皮肤市场（按地区）

第9章竞争形势

第10章章